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Abstract: In the present study, LC-HRESIMS-assisted dereplication along with bioactivity-guided
isolation led to targeting two brominated oxindole alkaloids (compounds 1 and 2) which probably
play a key role in the previously reported antibacterial, antibiofilm, and cytotoxicity of Callyspongia
siphonella crude extracts. Both metabolites showed potent antibacterial activity against Gram-positive
bacteria, Staphylococcus aureus (minimum inhibitory concentration (MIC) = 8 and 4 µg/mL) and Bacillus
subtilis (MIC = 16 and 4 µg/mL), respectively. Furthermore, they displayed moderate biofilm inhibitory
activity in Pseudomonas aeruginosa (49.32% and 41.76% inhibition, respectively), and moderate in vitro
antitrypanosomal activity (13.47 and 10.27 µM, respectively). In addition, they revealed a strong
cytotoxic effect toward different human cancer cell lines, supposedly through induction of necrosis.
This study sheds light on the possible role of these metabolites (compounds 1 and 2) in keeping fouling
organisms away from the sponge outer surface, and the possible applications of these defensive
molecules in the development of new anti-infective agents.
Keywords: Callyspongia siphonella; LC-HRESIMS; metabolomic profiling; oxindole alkaloids;
tisindoline; antibacterial; antibiofilm; antitrypanosomal; anticancer
1. Introduction
Marine sponges are prolific producers of diverse bioactive secondary metabolites that were
reported over the years [1,2]. These sessile marine animals developed a defensive chemical arsenal
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to keep small animals and plants (fouling organisms) away from settling on their outer surfaces [3].
Furthermore, these metabolites may also be used to regulate symbiotic bacterial populations known
to associate with sponges [4]. The genus Callyspongia belongs to the order Haplosclerida, family
Callyspongiidae. Callyspongia siphonella (Levi, 1965) is widely distributed throughout the Gulfs of
Aqaba and Suez from shallow water, but mostly deeper than 5 m [5]. Several bioactive secondary
metabolites including sipholane triterpenes [6], polyacetylenic alcohols [7], and amides [8] were
isolated from different members of this genus. In addition to these anticancer metabolites, a number of
steroidal anti-inflammatory compounds were also reported from this genus [9]. Pseudomonas aeruginosa
biofilms can cause serious infections especially for the elderly and immunocompromised patients.
Unfortunately, such infections often cannot be treated efficiently with common antibiotics [10,11].
A number of Callyspongia crude extracts showed potent antibacterial and antibiofilm activities toward
several pathogenic bacterial strains, particularly Pseudomonas aeruginosa PA01 [12]. In the present study,
bioactivity-guided fractionation together with LC-HRESIMS-assisted chemical investigation of the
Red Sea sponge C. siphonella led to the isolation of two antibacterial brominated oxindole alkaloids
(1,2) from a natural source for the first time along with several known metabolites. Compounds 1 and
2 showed considerable anti-biofilm activity in P. aeruginosa and moderate in vitro antitrypanosomal
activity. Moreover, they induced strong cell death in HT29, OVCAR-3, and MM.1S cancer cell lines
after 24-h stimulation.
2. Results and Discussion
2.1. Metabolomic Profiling
To date, a growing number of secondary metabolites were identified from Callyspongia siphonella
with diverse pharmacological effects [13]. Sipholane triterpenoids are considered the main characteristic
metabolites of this sponge. This class of metabolites was found to show a potent reversal of multidrug
resistance in tumor cells that overexpressed P-glycoprotein (P-gp) [14]. In addition, there are many
polyactylenes, polyketides, and alkaloids that were also reported from C. siphonella. In view of that,
metabolomic profiling of the marine sponge C. siphonella using LC-HRESIMS for dereplication purpose
resulted in the characterization of a variety of metabolites (Figure 1 and Figure S1) of which sipholane
triterpenes were found to be prevalent (Table 1). From the AntiMarine and Dictionary of Natural
Products (DNP) databases, a total of 24 compounds were tentatively identified. Seven compounds out of
these were members of the P-glycoprotein inhibitors, sipholane triterpenoids (3,4,20–24). Additionally,
the antiproliferative metabolites, callystatin A (16), hydroxydihydrobovolide (17), callyspongidic acid
(18), and callyspongendiol (19), were also dereplicated in the n-hexane fraction [15]. All sipholane
triterpenes are presumably derived from the cyclization of triepoxysqualenes. Detection of several
mass ion peaks proposed to be the biosynthetic intermediates of sipholane triterpenes supported the
previously suggested biosynthetic pathway (Scheme S1) [6]. Similarly, compounds 11, 12, 13, 14, and
15 were detected in the ethyl acetate fraction. Moreover, intermediate compounds suggesting that they
were involved in the biosynthesis of trisindoline (14) and its brominated derivatives (compounds 1 and
2) from tryptophan [16,17] were also found (Scheme S2). Tisindoline (14) is an antibiotic indole trimer
previously isolated from marine Vibrio and Shewanella species [18,19]. In addition to the identified
hits (Figure 1), other unidentified molecular formulae were detected, particularly in the ethyl acetate
fraction, suggesting the presence of further unknown metabolites. These findings, together with the
primary antibacterial screening, prioritized the ethyl acetate fraction for a further chemical investigation
to isolate the active metabolites.
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Table 1. Dereplication of the metabolites previously identified from Callyspongia siphonella.
NP Compound RT (min) [M + H]+ Calculated Mass Chemical Formula
1 Compound 1 a 3.21 442.0552 442.0555 C24H17N3OBr
2 Compound 2 a 3.32 442.552 442.0555 C24H17N3OBr
3 Sipholenol A c 5.96 477.3941 477.3944 C30H53O4
4 Sipholenone A c 6.41 475.3785 475.3787 C30H51O4
5 Callysterol c 7.12 401.381 401.3783 C28H49O
6 Cholestenone b 7.38 385.3472 385.347 C27H45O
7 5α-cholestanone b 7.41 387.3625 387.3627 C27H47O
8 Stigmasterone b 7.49 411.3634 411.3637 C29H47O
9 stigmasta-4,22-dien-3,6-dione b 6.95 425.345 425.342 C29H45O2
10 Petroselenic acid b 8.91 283.2634 283.2637 C18H35O2
11 Callyspongidipeptide A 2.26 227.139 227.1396 C11H19N2O3
12 Callysponginol sulfate A 2.6 459.2783 459.278 C24H43O6S
13 N-acetyl isatin b 2.7 190.0501 190.0504 C10H8NO3
14 Trisindoline b 2.86 364.1456 364.145 C24H18N3O
15 1,2,3,4-tetrahydro-1-methyl-β-carboline-3-carboxylic acid 2.99 231.1133 231.1134 C13H15N2O2
16 Callystatin A 3.83 457.3325 457.3318 C29H45O4
17 Hydroxydihydrobovolide 3.88 199.1339 199.1334 C11H19O3
18 Callyspongidic acid 3.95 395.2429 395.2434 C22H35O6
19 Callyspongendiol 4.51 437.3413 437.3420 C30H45O2
20 15,16-epoxy-22-hydroxysipholen-one A 5.18 507.3676 507.3686 C30H51O6
21 Sipholenoside B 5.34 623.452 623.4523 C36H63O8
22 Sipholenol G 5.39 493.3889 493.3893 C30H53O5
23 Sipholenoside A 5.63 621.4368 621.4366 C36H61O8
24 Sipholenone C 6.26 489.3562 489.3580 C30H49O5
a Isolated in the present study as a new natural product. b Isolated in the present study for the first time from C.
siphonella. c Previously reported from C. siphonella and confirmed by isolation.
2.2. Structure Characterization of the Isolated Compounds
The ethanolic extract of C. siphonella was partitioned with different organic solvents with increasing
polarity. The n-hexane and ethyl acetate fractions displayed weak to moderate antibacterial activities.
Further bioactivity-guided fractionation of the ethyl acetate fraction, which showed several new hits
upon LC-HRESIMS dereplication, led to the isolation of compounds 1 and 2.
Compound 1 was isolated as buff powder; the molecular formula C24H16ON3Br was suggested
on the basis of a positive HRESIMS ion at m/z 442.0554 [M + H]+, indicating 18 degrees of unsaturation.
1H-NMR spectral data of 1 (Table 2) in deuterated dimethyl sulfoxide (DMSO-d6) suggested the
presence of two exchangeable protons (δH 10.77, 11.03) due to NH. In addition, the splitting pattern
of resonances at δH 6.97 (H-7), 7.42 (H-6), and 7.30 (H-4), together with the 1H–1H COSY correlation
between (H-6) and (H-7), suggested the presence of a 1,3,4-trisubstituted benzene ring. The DEPTQ
spectrum (Table 2) displayed 16 signals, with 15 sp2 aromatic carbons including eight CH groups and
seven quaternary carbons, and one sp3 aliphatic quaternary carbon (C-3). The spectra also revealed an
aminocarbonyl at δC178.9 (C-2). The assignment of protonated carbons was achieved by the 1H–13C
HSQC data. The key HMBC correlations (Figure 2) from H-4 (δH 7.30, s, 1H) to C-3 (δC 53.2), and from
the exchangeable proton H-1(δH 10.77) to the carbonyl carbons C-2 (δC 178.9) and C-3a (δC 137.44)
together with the previous reported data [18], suggested the presence of a brominated indolin-2-one
skeleton at C-5 (δC 114). The presence of two identical indole moieties linked to brominated oxindole
moity at C-3 (δC 53.2) was figured out from the 1H-NMR spectral data (Table 2) and the 1H–13C HMBC
correlations (Figure 2). According to these data, HRESIMS analysis, and previously published data [20],
compound 1 was identified as 5-bromo trisindoline.
Compound 2 was isolated as a white amorphous powder. The molecular formula C24H16ON3Br
was suggested on the basis of the positive HRESIMS ion at m/z 442.0554 [M + H]+, indicating 18
degrees of unsaturation. HRESIMS and 1H and 13C-NMR spectra of 2 (Table 2) were almost identical
to that of compound 1. In addition, the similar two-dimensional (2D)-NMR correlations indicate that
compounds 1 and 2 are positional isomers, where the bromine is attached to C-6 instead of C-5. This
different attachment was confirmed from the 1H–13C HMBC correlation between H-4 (δH 7.16, d, 8Hz,
1H) and C-2 (δC 179); hence, compound 2 was identified as 6-bromo trisindoline.
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Both 5-bromotrisindoline (1) and 6-bromotrisindoline (2) are brominated indole trimers, previously
reported as synthetic intermediates [20,21] and isolated herein for the first time from a natural source.
Their parent non-halogenated trisindoline (14) was previously isolated from a marine bacterium
and exhibited significant antibacterial activity [18]. Only 5-bromotrisindoline (1) was reported as an
α-glycosidase enzyme inhibitor [20]. 1H-NMR and 13C-NMR assignments of 5-bromotrisindoline (1)
and 6-bromotrisindoline (2) are reported here for the first time based on extensive HSQC, COSY, and
HMBC analysis (Figures S3–S21, Supplementary Materials).
Further known metabolites, sipholenol A (3) and sipholenone A (4) [22], along with five steroidal
compounds, callysterol (5) [9], cholestenone (6), 5α-cholestanone (7) [23], stigmasterone (8) [24], and
stigmasta-4,22-dien-3,6-dione (9) [25], and one major fatty acid, petroselenic acid (10) [26,27], were also
isolated from the n-hexane fraction of C. siphonella (Figure 1). All isolated known metabolites were
identified based on their accurate mass analyses and comparison of their NMR spectroscopic data with
those reported in the literature (Figures S22–S47, Supplementary Materials). The triterpenes sipholenol
A (3) and sipholenone A (4) are major metabolites in C. siphonella. Sipholenol A (3) was previously
reported as a potent P-glycoprotein inhibitor in multidrug-resistant cancer cells [14]. Callysterol (5) is a
characteristic sterol in C. siphonella which exhibited in vitro anti-inflammatory activity [9]. The steroidal
compounds (6–9), along with the fatty acid petroselenic acid (10), were isolated here from C. siphonella
for the first time.
Table 2. 1H- (400 MHz) and 13C-NMR (100 MHz) for compounds 1 and 2 in DMSO-d6.
Compound 1 Compound 2
Position δH, mult. (J in Hz) δC, Type δH, mult. (J in Hz) δC, Type
1-NH 10.77 (br s, 1H) - 10.75, (br s, 1H) -
2 - 178.9, C - 179, C
3 - 53.2, C - 52.7, C
3a - 137.4, C - 134.3, C
4 7.30, (s, 1H) 127.8, CH 7.16, (d, 8Hz, 1H) 127.1, CH
5 - 114, C 7.12, (dd, 2Hz, 8Hz,1H) 124.6, CH
6 7.42, (d, 8Hz, 1H) 131.2, CH - 120.7, C
7 6.97, (d, 8Hz, 1H) 112.2, CH 7.14, (s, 1H) 112.8, CH
7a - 141.1, C - 143.5, C
1-NH’, 1-NH” 11.03 (br s, 2H) - 11.0, (br s, 1H) -
2′, 2′′ 6.89, (s, 2H) 124.9, CH 6.85, (d, 2.5Hz, 2H) 124.8, CH
3′, 3′′ - 113.6, C - 114.0, C
3′a, 3′′a - 126, C - 126, C
4′, 4′′ 7.22, (d, 8Hz, 2H) 121, CH 7.2, (d, 8Hz, 2H) 121, CH
5′, 5′′ 6.83, (t, 8Hz, 2H) 119, CH 6.81, (t, 8Hz, 2H) 118.8, CH
6′, 6′′ 7.04, (t, 8Hz, 2H) 121.5, CH 7.03, (t, 8Hz, 2H) 121.5, CH
7′, 7′′ 7.39, (d, 8Hz, 2H) 112.2, CH 7.35, (d, 8Hz, 2H) 112.1, CH
7′a, 7′′a - 137.4, C - 137.4, C
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2.3. Antibacterial Activity
For primary antibacterial screening, the crude ethanolic extracts, all fractions, and the isolated
compounds were evaluated against Staphylococcus aureus (ATCC 25923), Bacillus subtilis (ATCC 5230),
Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 9027). The antibacterial activity was
recorded as an inhibition zone diameter and measured as “mm” (Table 3). Ampicillin and gentamicin
were used as a positive control. The ethyl acetate fraction showed the highest inhibition against
Staphylococcus aureus (6.6 mm), Bacillus subtilis (5.4 mm), and Escherichia coli (1.5 mm), while the
n-hexane fraction exhibited mild antibacterial activity with inhibition zones ranging from 1 to 2 mm.
These findings are in great accordance with the previously reported antibacterial activity of C. siphonella
extracts [28]. Compounds 1 and 2 derived from the ethyl acetate fraction displayed potent antibacterial
activity against Gram-positive bacteria S. aureus and B. subtilis with inhibition zones of 17.5 mm and
18 mm, and 15 mm and 16.4 mm, respectively (Table 4). With respect to Gram-negative bacteria E. coli
and P. aeruginosa, 1 and 2 showed weak antibacterial activity with inhibition zones of 0.5 mm and
1.3 mm, and 0.2 mm and 1.1 mm, respectively. The other isolated compounds (3–10) did not exhibit any
inhibition against the tested bacterial strains. The minimum inhibitory concentration (MIC) values of 1
and 2 that showed antibiotic activity in disc diffusion tests were determined (Table 5). It was observed
that the MIC value of 2 against S. aureus (16 µg/mL) was higher than that of 1 (8 µg/mL). However,
both compounds exhibited potent inhibitory effect toward B. subtilis with an MIC value of 4 µg/mL.
In a previous study [18], their parent compound, trisindoline (14), showed antibacterial activity against
both Gram-positive and Gram-negative bacterial strains; hence, incorporation of a bromine atom into
the oxindole moiety of trisindoline (14) reduces the antibacterial spectrum of these molecules. From the
previous observations, we can conclude that the bromotrisindolines (1,2) may be the main metabolites
responsible for the antibacterial activity of C. siphonella extract against Gram-positive bacteria.
Table 3. Inhibition zone diameter (mm) of the ethanol extract and fractions of C. siphonella on different
bacterial strains (mean ± standard error (SE).
Tested Extract Staphylococcus aureus Bacillus subtilis Escherichia coli Pseudomonas aeruginosa
EtOH Ext 1.1 ± 0.5 1.2 ± 0.2 - -
Hex 2.3 ± 0.9 1.1 ± 0.4 - 1 ± 0.4
EtOAc 6.6 ± 0.2 5.4 ± 0.3 1.5 ± 0.7 -
ButOH - 0.5 ± 0.2 - -
Ampicillin 13.7 ± 0.9 12.3 ± 1.2 3.9 ± 0.9 3.6 ± 0.3
Gentamicin 9.8± 1.2 10.1 ± 1.1 15.5 ± 0.1 14.8 ± 1.3
Ampicillin, gentamicin, extracts, and fractions (20 µg/mL DMSO). EtOH, ethanol extract; Hex, n-hexane fraction;
EtOAc, ethyl acetate fraction; ButOH, n-butanol fraction. (-) indicates no growth inhibition found.
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Table 4. Inhibition zone diameter (mm) of 1 and 2 on different bacterial strains (mean ± SE).
Tested Compound S. aureus B. subtilis E. coli P. aeruginosa
1 17.5 ± 0.8 18 ± 0.1 0.5 ± 0.1 1.3 ± 0.3
2 15 ± 1.1 16.4 ± 0.9 0.2 ± 0.2 1.1 ± 0.7
Amikacin 23.5 ± 0.8 20.2 ± 0.6 15.4 ± 0.4 16.3 ± 0.9
Table 5. Minimal inhibitory concentration (MIC) (µg/mL) values of 1 and 2.
Fungal Metabolite S. aureus B. subtilis E. coli P. aeruginosa
1 8 4 >256 256
2 16 4 >256 256
Ampicillin 2 2 4 8
Gentamicin 16 8 0.5 1
2.4. Antibiofilm Activity
As demonstrated from the antibacterial screening, metabolites 1 and 2 did not exhibit any inhibition
against the Gram-negative bacteria, P. aeruginosa PAO1. However, compounds that have no direct
growth inhibitory effect on the pathogenic organisms still have the potential to act as biofilm formation
inhibitors. As outlined in a recent review [29], many categories of natural products, including marine
invertebrate-derived metabolites can stop the formation of biofilms and, thus, comprise candidates
for adjuvant therapy as boosters of the common antibiotics. Therefore, all isolated compounds were
tested against P. aeruginosa to determine if they could inhibit biofilm formation. Compound 1 reduced
biofilm formation slightly more (49.32% inhibition) than 2 (41.76%) at concentrations of 128 µg/mL (0.5
MIC) (Table 6). The remaining compounds were inactive at tested concentrations. To the best of our
knowledge, none of the derivatives of trisindoline antibiotic are so far associated with inhibition of
biofilm formation in human pathogens. Therefore, further mechanistic studies on these compounds
are needed.
Table 6. Antibiofilm activity of 1 and 2 in Pseudomonas aeruginosa PA01.
Isolated Compound % Inhibition
1 49.32 ± 1.18
2 41.76 ± 1.33
Azithromycin 52.62 ±1.23
Each compound was tested at concentration of 128 µg/mL (0.5 MIC). Azithromycin was tested at a concentration of
16 µg/mL (0.5 MIC).
2.5. Antitrypanosomal Activity
African trypanosomiasis, which is also known as sleeping sickness, is a fatal and neglected disease
caused by Trypanosoma brucei, affecting mostly the poor people living in tropical and subtropical
zones [30]. The increasing resistance to the current medications necessitated the development of novel
alternatives to fight this disease. Natural products will continue to play a vital role in the search
for new antitrypanosomal drugs. All isolated compounds were tested against the sleeping sickness
parasite, T. brucei. Both metabolites 1 and 2 demonstrated moderate antitrypanosomal activity after 48
and 72 h with half maximal inhibitory concentration (IC50) values of 15.36 (48 h) and 13.47 (72 h), and
12.35 (48 h), and 10.27 (72 h) µM, respectively. However, the other isolated compounds were found
inactive against T. brucei.
2.6. Cytotoxic Activity
Crystal violet and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays
were used to assess the cytotoxicity of all isolated metabolites against three different cancer cell lines
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over a concentration range of 0.01–50 µM. Both 1 and 2 revealed significant cytotoxic effects (Table 7)
against all cell lines under investigation (human colon cancer cell line: HT-29, human ovarian cancer
cell line: OVCAR-3, and multiple myeloma cell line: MM.1S). Furthermore, the microscopic pictures
showed clear changes in cell morphology after overnight treatment with 1 (Figures 3 and 4). However,
the Western blotting analysis showed only a decrease in the level of procaspase-3 but unfortunately,
we neither detected any split caspase-3 products, the key protein of apoptosis, nor changes in the level
of beclin protein, one of the master proteins of autophagy (Figure 5). Moreover, 1 was not able to
induce the upregulation of proinflammatory cytokines such as interleukin-8 (IL8) in MM.1S and HT-29
(Figure S2, Supplementary Materials). Our previous results and many previous publications showed
that the programmed cell death is usually accompanied by the induction of proinflammatory signals
such as IL8 [31,32]. This confirms the Western blotting results that compound 1 kills the cancer cells by
non-programmed cell necrosis but not by programmed cell death mechanisms such as necroptosis,
apoptosis, or autophagy.
Table 7. Cytotoxic effects of 1 and 2 expressed by half maximal inhibitory concentration (IC50) values.
Compounds
IC50 (µM) a
HT-29 OVCAR-3 MM. 1S
1 8 ± 0.8 7 ± 0.3 9 ± 0.7
2 12.5 ± 0.3 9 ± 0.6 11 ± 0.9
a Values are means of three independent experiments. human colon cancer cell line: HT-29; human ovarian cancer
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3. Material and Methods
3.1. Extraction and Fractionation
The marine sponge C. siphonella (2 kg) was collected in November 2015 from Hurghada along
the Red Sea Coast (27◦15048” north (N), 33◦4903” east (E)) at depth of 7 m. A voucher sample
(NIOF204/2015) was reserved at the Invertebrates Department, National Institute of Oceanography
and Fisheries, Red Sea Branch, Hurghada, Egypt. Subsequently, sponge material was cut into small
pieces, and then subjected to ultrasonic-assisted extraction with ethanol (3 × 500 mL). The resulted
liquid extract was concentrated using a rotary evaporator (IKA®, Staufen, Germany). The obtained
concentrated extract was suspended in distilled water and fractionated with n-hexane (4 × 200 mL),
ethyl acetate (3 × 200 mL), and n-butanol (3 × 200 mL). All fractions were separately concentrated
under reduced pressure and screened for their antibacterial activities.
3.2. Metabolomics Analysis
Metabolomic profiling was performed on the crude extract of C. siphonella on an Acquity Ultra
Performance Liquid Chromatography system coupled to a Synapt G2 HDMS quadrupole time-of-flight
hybrid mass spectrometer (Waters, Milford, CT, USA). Chromatographic separation was carried
out on a BEH C18 column (2.1 × 100 mm, 1.7 µm particle size; Waters, Milford, CT, USA) with a
guard column (2.1 × 5 mm, 1.7 µm particle size) and a linear binary solvent gradient of 0–100%
eluent B over 6 min at a flow rate of 0.3 mL·min−1, using 0.1% formic acid in water (v/v) as solvent
A and acetonitrile as solvent B. The injection volume was 2 µL and the column temperature was
40 ◦C. Ms converter software was used in order to convert the raw data into divided positive and
negative ionization files. Obtained files were then subjected to the data mining software MZmine 2.10
(Okinawa Institute of Science and Technology Graduate University, Japan) for deconvolution, peak
picking, alignment, deisotoping, and formula prediction. The databases used for the identification of
compounds were: MarinLit: http://pubs.rsc.org/marinlit/, and Dictionary of Natural Products (DNP)
2018: http://dnp.chemnetbase.com/faces/chemical/ChemicalSearch.xhtml.
3.3. Assessment of Antibacterial Activity
The tested microorganisms used in this study included Gram-positive (Staphylococcus aureus,
ATCC 25923 and Bacillus subtilis ATCC 5230) and Gram-negative (Escherichia coli ATCC 25922 and
Pseudomonas aeruginosa ATCC 9027) pathogenic bacteria. An agar well diffusion assay was used to
investigate the antibacterial activity of all sponge extracts and fractions [33]. Minimal inhibitory
concentrations (MIC) were determined by the broth dilution method for isolated compounds according
to Clinical and Laboratory Standards Institute (CLSI) protocol [34].
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3.4. Bioactivity-Guided Isolation of the Major Metabolites
After a preliminary assessment of all prepared fractions and extracts for antibacterial activities, the
ethyl acetate fraction (2 g) was the most active against Gram-positive bacteria. Further fractionation on
silica gel column (60–120 mesh, Fluka®) using n-hexane/ethyl acetate in a gradient elution, resulted in
three sub-fractions (codes F1–F3). Afterward, the active sub-fraction F3 (400 mg) was chromatographed
on Agilent® 1260 Infinity preparative HPLC using acetonitrile in water (70–100%) for 20 min followed
by 100% acetonitrile for the next 10 min at a 20 mL/min flow rate to afford 1 (21 mg) and 2 (25 mg).
Similarly, the less active n-hexane fraction was fractionated on a silica gel column using n-hexane/ethyl
acetate in a gradient elution to give six sub-fractions (codes F1–F6). Subfraction F1 (600 mg) was
chromatographed on a silica gel column using n-hexane/ethyl acetate in a gradient elution to afford
10 (40 mg) and 7 (15 mg). In the same manner, subfraction F2 (350 mg) was chromatographed on
silica gel column using n-hexane/ethyl acetate in a gradient elution to afford 6 (15 mg) and 8 (20 mg).
Furthermore, subfractions F3–F5 (250 mg) were combined and chromatographed on a silica gel column
using dichloromethane/methanol in a gradient elution to afford 9 (15 mg), 5 (30 mg), 4 (50 mg), and 3
(100 mg). The structure of the isolated compounds was elucidated by comparison of their spectral
data (MS and NMR) with those reported in the literature. MS and NMR spectra were recorded on
Agilent series 1100 SL (Agilent CO, Santa Clara, CA, USA) and Bruker Avance III 400 MHz (Bruker
AG, Switzerland), respectively.
3.5. Screening of Antibiofilm Activity
The assay was performed as previously described by Drenkard and Ausubel (2002) [35] with
minor modifications. Briefly, PseudomonasaeruginosaPAO1 was cultured in lysogeny broth (LB) medium
(Himedia®, Mumbai, India). After incubation, cultures were vortexed, diluted 1:100 in fresh LB medium
for biofilm formation, and cultured with or without the tested natural products and azithromycin
(AZM) (Sigma Aldrich®, Munich, Germany) for 24 h at 37 ◦C. Then, the non-adherent cells were
washed with phosphate-buffered saline (PBS), while adherent ones were subjected to 1% crystal violet
staining for 15 min. The wells were washed again with water to get rid of excess stain. After the wells
dried, the crystal violet obligated to the biofilm was extracted with 95% ethanol. The crystal violet
solution absorbance (in optical density units, OD) was measured at 570 nm. AZM was reported as a
biofilm inhibitor at the sub-inhibitory concentration [36]; thus, it was used as a positive control in the
bioassay. Percentage inhibition was calculated according to the following rule:
% of inhibition =
Control OD − Test OD
Control OD
× 100.
3.6. Antitrypanosomal Activity Testing
The antitrypanosomal activity was tested against Trypanosoma brucei strain TC221 according to
the Huber and Koella protocol [37]. The growth inhibitory activity was measured using an MR 700
microplate reader at wavelengths of 550 and 650 nm. IC50 values were calculated by linear interpolation
of three independent measurements. Samples were considered active when their IC50 values were less
than 20 µM.
3.7. Cytotoxic Activity Assessment
Cell lines were maintained in earth RPMI 1640 medium (HT-29 and MM.1S cells) or in DMEM
medium (OVCAR-3 cells) containing 10% heat-inactivated fetal bovine serum (FBS), and were
grown at 37 ◦C and 5% CO2. Anti-caspase-3 (#9662) and anti-beclin (#3495S) were purchased from
Cell Signaling (Beverly, MA, USA), and anti-β-actin (monoclonal AC015) from Sigma (Louis, Mo
363103 USA). Cell lines were counted and seeded on 96-well cell culture plates (2 × 104 cells/well
in the case of HT-29 and OVCAR-3 and 6 × 104 cells/well in the case of MM.1S cells). Cells were
stimulated either in the next day in the case of HT-29 and OVCAR-3 or on the same day in the
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case of MM.1S cells with the indicated concentrations of each compound overnight in triplicates.
Cell viability was assessed either by crystal violet staining in the case of HT-29 and OVCAR-3 or
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in the case of MM.1S
cells [38]. To normalize cell viability values, each plate included a triplicate of untreated cells considered
as 100% viability, and a triplicate of cells treated with a cytotoxic mixture (200 ng/mL TNF, 200 ng/mL
CD95L, 200 ng/mL TRAIL, 5 µg/mL CHX, 1% (w/v) sodium azide 20%) considered as 0% viability.
All other viability values were normalized according to the averages of these triplicates and analyzed
by the Graph Pad Prism 5 software (La Jolla, CA, USA).
3.8. Western Blotting
Cells were seeded in six-well plates (1 × 106/well) and stimulated with 40 µM of compound
4. In the next day, cells were harvested in ice-cold PBS and washed by centrifuging cells twice in
PBS and centrifuged for 4 min at 1200 rpm (4◦C). Then, total cell lysates were prepared as described
before in our previous work [32]. The membranes were incubated overnight with primary antibodies
and antigen-antibody reactions were performed in the next day using the corresponding secondary
antibodies (anti-mouse-HRP, Dako-Cytomation, Hamburg, Germany; anti-rabbit-HRP, Cell Signaling
Technology). The specific bands were visualized using ECL detection reagents for Western blotting
(Amersham Biosciences, Germany).
3.9. IL8 ELISA
Firstly, 2 × 104 of MM.1S and HT-29 cells per well were seeded in 96-well plates. On the next
day, the medium was changed to reduce the background of constitutive IL8 production, and cells
were incubated with the indicated reagent(s) for 16 h. The supernatants were collected and analyzed
for production of IL8 using the human IL8 ELISA (enzyme-linked immunosorbent assay) kit BD
Biosciences (Heidelberg, Germany) according to the instructions of the supplier.
4. Conclusion
The present study clearly highlighted the efficacy of LC–MS profiling when coupled to bio-guided
drug discovery from marine invertebrates to speed up the traditionally long processes of identifying
an active metabolite by consecutive isolation from crude extracts. Dereplication studies based on the
chemotaxonomic sorting helped in the identification of putative active metabolites, whereas structural
assignment of the isolated compounds, employing both HR-MS and NMR, confirmed the identified
hits. Thus, bio-guided isolation coupled to LC–MS metabolomic profiling of the Red Sea sponge
C. siphonella led to the characterization of two brominated indole alkaloids (1,2), which were not
isolated from natural sources before. Moreover, metabolomics analysis gave insight into the metabolic
pathways required for the biosynthesis of compounds 1 and 2 from tryptophan, together with the
characteristic sipholane triterpenoids from squalene. Compounds 1 and 2 showed excellent in vitro
antibacterial activity against the tested Gram-positive strains and displayed significant anti-biofilm
activity in P. aeruginosa. Moreover, they exhibited considerable in vitro antitrypanosomal activity, and
were able to trigger potent cell death in a few tumor cell lines. Western blotting together with IL8
assay results suggested that compounds 1 and 2 could mediate their cytotoxicity via necrosis induction.
The present investigation sheds the light on how C. siphonella can defend itself chemically within
its hostile marine environment and the possible utilization of its defensive metabolites in the future
development of new anti-infective agents. Further in vivo biological evaluation of these interesting
bis-indoles will be of value for future drug development.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/8/465/s1:
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Figures S1–S47: One-dimensional and two-dimensional (1D and 2D) NMR spectra of isolated compounds.
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